Clinical Trial Update: Treatment of in-Stent Restenosis by Paclitaxel Coated PTCA Balloons (PACCOCATH - ISR II) [Phase 1, Phase 2]

View source ↗

Summary

Completed Phase 1/2 study evaluating paclitaxel-coated PTCA balloons (PACCOCATH ISR II) for treatment of in-stent restenosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Restenosis

Drugs mentioned

• paclitaxel-coated PTCA balloon (PACCOCATH ISR II) (paclitaxel)

Snippet

Sponsor: University Hospital, Saarland | Conditions: Coronary Restenosis | Phase 1, Phase 2 | Status: COMPLETED